The US President Joe Biden publishes an executive order containing 72 initiatives to address competition concerns in several industries, including pharmaceuticals, biotech, and healthcare

Citing concerns about growing consolidation, reduced competition, and increasing prices, President Biden issued on July 9, 2021 a sweeping Executive Order containing 72 initiatives to address competition concerns in a number of industries, including pharmaceuticals, biotech, and healthcare. In his remarks at the signing of the July 9, 2021 Executive Order, President Biden focused on three specific initiatives, the first of which relates to lowering prescription drug prices. "Americans are paying too much for prescription drugs and healthcare services — far more than the prices paid in other countries," the Executive Order declares. The Executive Order simultaneously backs legislative proposals to address drug prices, and directs agencies to take specific action designed to facilitate

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Michael Gallagher, Kristen O'Shaughnessy, Kathryn Jordan Mims, Kevin Adam, Jaclyn Phillips, The US President Joe Biden publishes an executive order containing 72 initiatives to address competition concerns in several industries, including pharmaceuticals, biotech, and healthcare, 9 July 2021, e-Competitions July 2021 - II, Art. N° 101504

Visites 218

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues